Cargando…
The Role and Potential of (18)F-FDG PET/CT in Malignant Melanoma: Prognostication, Monitoring Response to Targeted and Immunotherapy, and Radiomics
Novel therapeutic approaches, consisting of immune check-point inhibitors (ICIs) and molecularly targeted therapy, have thoroughly changed the clinical management of malignant melanoma (MM), the most frequent and deadly skin cancer. Since only 30–40% of MM patients respond to ICIs, imaging biomarker...
Autores principales: | Filippi, Luca, Bianconi, Francesco, Schillaci, Orazio, Spanu, Angela, Palumbo, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028862/ https://www.ncbi.nlm.nih.gov/pubmed/35453977 http://dx.doi.org/10.3390/diagnostics12040929 |
Ejemplares similares
-
PET/CT with (18)F-choline or (18)F-FDG in Hepatocellular Carcinoma Submitted to (90)Y-TARE: A Real-World Study
por: Filippi, Luca, et al.
Publicado: (2022) -
Value of Shape and Texture Features from (18)F-FDG PET/CT to Discriminate between Benign and Malignant Solitary Pulmonary Nodules: An Experimental Evaluation
por: Palumbo, Barbara, et al.
Publicado: (2020) -
Usefulness of PET/CT with (18)F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study
por: Filippi, Luca, et al.
Publicado: (2021) -
Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism on (18)F-FDG PET/CT and Automated Classifiers
por: Nuvoli, Susanna, et al.
Publicado: (2022) -
Colonic Malignant Melanoma: (18)F-FDG PET/CT Findings
por: Kaya, Eser, et al.
Publicado: (2018)